Partnerships, collaborations ... The trade for Hemarina is to have a pharma background experienced competency ex gratia. It is ruled and governed by a three parties convention where all ...

Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2025Iconovo and Lonza have entered a collaboration to develop spray-dried formulations of an intranasal biologic drug for Iconovo's proprietary intranasa ...

Ironwood Pharmaceuticals, Inc.’s IRWD share price has dipped by 15.22%, which has investors questioning if this is right time ...

Knipper Health, a leading healthcare solutions organization serving the pharmaceutical, biotechnology, and medical device ...

Evis Healthcare Ltd., the driving force behind the premium fitness supplement brand Bolt Nutrition, is thrilled to announce a ...

Arcutis looks promising, driven by strong Zoryve sales, a solid balance sheet, and a strategic CFO transition. See why I rate ...

For the first quarter of 2025, a Class A investment in Laughing Water Capital returned approximately -13%. Over the same ...

OCTOBER 28, 2024 — UTSA was selected for a new grant that will foster a partnership with ... drug candidates. This background provided him with an in-depth understanding of the issues process chemists ...

Epigenetic reprogramming holds promise for reversing aging, addressing cellular aging mechanisms and paving the way for innovative therapeutic strategies.

Mr. Malone is a 2nd generation financial advisor with over 40 years of family experience in wealth management. This combined with his deep entrepreneurial background he launched Malone Wealth in 2021.

Entrepreneur News proudly launches its April-June 2025 digital edition, spotlighting the Top 10 Business Icons of ...